iPharma Center

352 posts

iPharma Center

iPharma Center

@ipharma_center

Business account of iPharmaCenter. Please DM for business related messages

Katılım Mart 2023
2 Takip Edilen0 Takipçiler
iPharma Center
iPharma Center@ipharma_center·
BeOne presented data of Brukinsa at #ASCO26 #ASCO2026 #CancerResearch #Oncology #Hematology #BloodCancer #ClinicalTrials #PrecisionMedicine #CancerImmunotherapy #GlobalHealth #ClinicalOncology #CancerScience #MolecularOncology #PatientCare #MedicalCongress
ipharmacenter@ipharmacenter

#ASCO26 - #ASCO26 is starting soon, and we’ll be tracking the data, practice‑changing trials and real‑time highlights – follow all the latest #ASCO2026 updates in one place at @ipharmacenter Link in the comments #Cancer #OncoAlert #ASCO26 #ASCO2026 #innovation #oncology

Filipino
1
0
0
4
iPharma Center
iPharma Center@ipharma_center·
#BREAKING: Longest next-gen BTK inhibitor follow-up data ever reported in #CLL SEQUOIA trial delivers 78-month results for #zanubrutinib vs #bendamustine-#rituximab in first-line CLL ipharmacenter.com/post/american-… #pharma #ASCO2026 #ASCO26 #Cancer #OncoAlert #ASCO26withiPharmaCenter
ipharmacenter@ipharmacenter

#ASCO26 - #ASCO26 is starting soon, and we’ll be tracking the data, practice‑changing trials and real‑time highlights – follow all the latest #ASCO2026 updates in one place at @ipharmacenter Link in the comments #Cancer #OncoAlert #ASCO26 #ASCO2026 #innovation #oncology

English
0
0
0
1
iPharma Center
iPharma Center@ipharma_center·
#AstraZeneca’s #Imfinzi Reduces Recurrence Risk in High-Risk NMIBC, Wins #US #FDA Approval The Phase III POTOMAC trial shows adding Imfinzi to BCG therapy reduced the risk of recurrence or death by 32% in patients with high-risk NMIBC ipharmacenter.com/post/imfinzi-s… #news #ASCO26 #media
ipharmacenter@ipharmacenter

#ASCO26 - #ASCO26 is starting soon, and we’ll be tracking the data, practice‑changing trials and real‑time highlights – follow all the latest #ASCO2026 updates in one place at @ipharmacenter Link in the comments #Cancer #OncoAlert #ASCO26 #ASCO2026 #innovation #oncology

English
1
0
0
5
iPharma Center
iPharma Center@ipharma_center·
Follow last #ECO2026 updates with @ipharmacenter #pharma #ECO2026 #ECO26 #news #media #breaking #obesity #EliLilly #innovation #weightloss #Obesitycare $LLY $NVO #ECO2026
ipharmacenter@ipharmacenter

SURMOUNT-MAINTAIN trial evaluated dose adjustments within #Zepbound therapy. Patients who continued on the MTD for an additional year maintained their #weightloss ipharmacenter.com/post/european-… #pharma #ECO2026 #ECO26 #news #media #breaking #obesity #EliLilly #innovation

English
0
0
0
2
iPharma Center
iPharma Center@ipharma_center·
Follow last #ECO2026 updates with @ipharmacenter #pharma #ECO2026 #ECO26 #news #media #breaking #obesity #EliLilly #innovation #weightloss #Obesitycare $LLY $NVO #ECO2026
ipharmacenter@ipharmacenter

In the ATTAIN-MAINTAIN study, patients who switched from the maximum tolerated dose of #Wegovy (semaglutide) to #Foundayo largely preserved their earlier weight reduction ipharmacenter.com/post/european-… #pharma #ECO2026 #ECO26 #news #media #breaking #obesity #EliLilly #innovation

English
0
0
0
3
iPharma Center
iPharma Center@ipharma_center·
#CMS launched ACCESS Model in the #UnitedStates ipharmacenter.com/post/cms-launc… #pharma #pharmaceutical #Trump #PresidentTrump #Medicaid #Medicare #DigitalHealth #PopulationHealth #USNews #USA
ipharmacenter@ipharmacenter

#CMS launched the 10-year #ACCESSModel in Original #Medicare to test outcome-aligned payments and tech-enabled care for high-burden chronic conditions ipharmacenter.com/post/cms-launc…​ #CMS #Medicare #news #Trump #BreakingNews #Hypertension #Diabetes #Depression #PresidentTrump #media

English
0
0
0
9
iPharma Center
iPharma Center@ipharma_center·
Follow #SABCS25 and ASH25 on #ipharmacenter for continuous updates ipharmacenter.com/post/best-sell… #pharma #pharmaceutical #healthcare #globalhealth #cancer #oncology #cancerresearch #OncoTwitter #OncoAlerts #OncoAlert #CancerAwareness #conferences #Oncology
ipharmacenter@ipharmacenter

Find the list of top #pharmaceutical companies by revenues in 2025 ipharmacenter.com/post/top-10-ph… #pharma #pharmaceutical #trump #presidenttrump #Medicare #Medicaid #CMS #healthcare #neurology #oncology #rheumatology #SABCS25 #news #media #top10

English
0
0
0
1
iPharma Center
iPharma Center@ipharma_center·
Follow #SABCS25 and ASH25 on #ipharmacenter for continuous updates ipharmacenter.com/post/best-sell… #pharma #pharmaceutical #healthcare #globalhealth #cancer #oncology #cancerresearch #OncoTwitter #OncoAlerts #OncoAlert #CancerAwareness #conferences #Oncology
ipharmacenter@ipharmacenter

#Imfinzi + FLOT is now FDA-approved as the first perioperative #immunotherapy for resectable stage II–IVA gastric and GEJ cancers, based on positive MATTERHORN data ipharmacenter.com/post/fda-clear…​ #news #media #gastriccancer #GEJcancer #Immunotherapy #OncoTwitter #OncoAlert #OncoAlerts

English
0
0
0
0
iPharma Center
iPharma Center@ipharma_center·
For any support on competitive intelligence, syndicate reports, pricing and market access, market research projects, please write to info@ipharmacenter.com. #GI25 #ASCO #pharma #pharmaceutical #healthcare #marketaccess
ipharmacenter@ipharmacenter

#Gi25 - #Pfizer's Targeted Therapy Shows Promising Results for Metastatic #ColorectalCancer with BRAF V600E Mutation ipharmacenter.com/post/bristol-m… #pharma #pharmaceutical #Science #news #media #medicine #DiGiTALhealth #ASCOGI25 #USA #patientcare #healthcare #MedComms #MedicalAffairs

English
0
0
0
16
iPharma Center
iPharma Center@ipharma_center·
For any support on competitive intelligence, syndicate reports, pricing and market access, market research projects, please write to info@ipharmacenter.com. #GI25
ipharmacenter@ipharmacenter

#BMS Unveils Promising Results from CheckMate -8HW Trial on Opdivo + Yervoy Combo for Metastatic Colorectal #Cancer ipharmacenter.com/post/bristol-m… #pharma #pharmaceutical #Science #news #media #medicine #DiGiTALhealth #ASCOGI25 #USA #patientcare #healthcare #MedComms #MedicalAffairs

English
0
0
0
2
iPharma Center
iPharma Center@ipharma_center·
For any support on competitive intelligence, syndicate reports, pricing and market access, market research projects, please write to info@ipharmacenter.com. #GI25
ipharmacenter@ipharmacenter

#Gi25 - #Pfizer's Targeted Therapy Shows Promising Results for Metastatic #ColorectalCancer with BRAF V600E Mutation ipharmacenter.com/post/bristol-m… #pharma #pharmaceutical #Science #news #media #medicine #DiGiTALhealth #ASCOGI25 #USA #patientcare #healthcare #MedComms #MedicalAffairs

English
0
0
0
2

Keşfet

@ipharmacenter @elonmusk @BarackObama @taylorswift13 @cristiano @BillGates @NASA @nikifrancismediavine